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Background: Transmission of arthropod-borne apicomplexan parasites that cause disease and result in death or
persistent infection represents a major challenge to global human and animal health. First described in 1901 as
Piroplasma equi, this re-emergent apicomplexan parasite was renamed Babesia equi and subsequently Theileria equi,
reflecting an uncertain taxonomy. Understanding mechanisms by which apicomplexan parasites evade immune or
chemotherapeutic elimination is required for development of effective vaccines or chemotherapeutics. The
continued risk of transmission of T. equi from clinically silent, persistently infected equids impedes the goal of
returning the U. S. to non-endemic status. Therefore comparative genomic analysis of T. equi was undertaken to: 1)
identify genes contributing to immune evasion and persistence in equid hosts, 2) identify genes involved in PBMC
infection biology and 3) define the phylogenetic position of T. equi relative to sequenced apicomplexan parasites.
Results: The known immunodominant proteins, EMA1, 2 and 3 were discovered to belong to a ten member gene
family with a mean amino acid identity, in pairwise comparisons, of 39%. Importantly, the amino acid diversity of
EMAs is distributed throughout the length of the proteins. Eight of the EMA genes were simultaneously transcribed.
As the agents that cause bovine theileriosis infect and transform host cell PBMCs, we confirmed that T. equi infects
equine PBMCs, however, there is no evidence of host cell transformation. Indeed, a number of genes identified as
potential manipulators of the host cell phenotype are absent from the T. equi genome. Comparative genomic
analysis of T. equi revealed the phylogenetic positioning relative to seven apicomplexan parasites using deduced
amino acid sequences from 150 genes placed it as a sister taxon to Theileria spp.
Conclusions: The EMA family does not fit the paradigm for classical antigenic variation, and we propose a novel
model describing the role of the EMA family in persistence. T. equi has lost the putative genes for host cell
transformation, or the genes were acquired by T. parva and T. annulata after divergence from T. equi. Our analysis
identified 50 genes that will be useful for definitive phylogenetic classification of T. equi and closely related
organisms.
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Equine piroplasmosis of horses, mules, donkeys and
zebras is caused by the tick-borne apicomplexan proto-
zoan parasites Babesia caballi and Theileria equi,
transmitted by ixodid ticks such as Dermacentor nitens
(B. caballi) and Rhipicephalus microplus (T. equi) [1,2].
Although endemic in most countries [3], the U. S., until
recently, has been considered free of infection. Equine
infections in Florida with B. caballi and T. equi were
diagnosed between 1961 and 1969 leading to an eradica-
tion campaign which lasted twenty-five years and cost
twelve million dollars [4]. The re-emergence of T. equi in
Florida [4] and Texas [5] raised concern of its further
spread within the U. S., and indeed, infected horses have
been identified in 12 states [6,7]. The cause of the 2008
Florida outbreak was due to iatrogenic transmission, but
two tick species, Amblyomma cajennense and D. variabilis,
were identified as novel vectors in the 2009 Texas out-
break [5]. The re-emergence of this pathogen in the U.S.
impacts global movement and health of horses and affects
the multi-billion dollar equine industry.
Additional members of the phylum Apicomplexa,
important to global human and animal health include
the organisms in the genus Plasmodium as well as T. parva
and T. annulata, and Babesia bovis causes of malaria,
bovine theileriosis and babesiosis, respectively. The phylo-
genetic position of T. equi has been controversial, and
the organism has been renamed several times [8]. Mo-
lecular phylogenetic analyses indicate an intermediate
position for T. equi between B. bovis and Theileria spp.
[9,10] and is supported by the genomic data presented
here which provides the deepest phylogenetic analysis to
date. Collective data supports the concept that a new
genus placement sister to Theileria may be appropriate
for T. equi.
Similar to bovine theileriosis caused by T. annulata,
transmission of T. equi to equids eventually results in
lysis of erythrocytes and prolonged anemia. Anemia
associated with T. parva occurs later during infection
and is comparatively and clinically mild [11]. Infection
of B- and T-lymphocytes by T. parva and mononuclear
phagocytes and B-lymphocytes by T. annulata lead to
reversible cell transformation [12]. Infection of periph-
eral blood mononuclear cells (PBMCs) by T. equi has
been reported [8,13]. However the role of PBMC infec-
tion in the pathogenesis of T. equi, unlike T. parva and
T. annulata remains unresolved, and PBMC prolifera-
tion and/or transformation have not been associated
with clinical equine piroplasmosis.
The primary clinical outcome of acute T. equi infec-
tion is anemia and the associated erythrolysis is inde-
pendent of parasite-specific immune responses [14].
Resolution of acute disease is followed by apparent life-
long parasite persistence within equids [15]. Persistenceis characterized by the continuous presence of 103 to
106 infected peripheral erythrocytes per ml/blood result-
ing in efficient acquisition and transmission by ticks
[16]. A hallmark of pathogens that establish persistent
infection and avoid immune elimination is the presence
of an immunodominant, variable multigene family re-
sponsible for immune evasion, such as VESA1 (Variant
Erythrocyte Surface Antigen 1) in B. bovis [17], PfEMP1
(Erythrocyte Membrane Protein 1) in P. falciparum [18]
and VSG in T. brucei [19]. An analogous family was not
detected in T. equi. A candidate multigene gene family
in T. equi encodes Equi Merozoite Antigens (EMAs),
which are immunodominant for antibody, however, this
family contains just 10 members, and lacks an apparent
structural basis for variation. The reemergence and per-
sistence of T. equi in the U. S. prompted this genomic
research due to the lack of a vaccine to block infection
or clinical disease and the need for additional che-
motherapeutics aimed at eliminating persistent infection
and tick-borne transmission risk.
Results and discussion
Chromosome arrangement and content
The genomic complement of T. equi contains six mole-
cules, including four chromosomes (Figure 1) of ~11.6
Mbp, an apicoplast genome of 47.8 kbp and a mitochon-
drial genome of 9 kbp. Chromosomes 1 (3,677,484 bp)
and 3 (2,338,319 bp) were completely assembled, while
chromosome 2 (2,060,349 bp) contains one assembly
gap. Chromosome 4 (3,480,987 bp) is fragmented into
six pieces with four physical gaps and one assembly gap.
The chromosome assemblies agree with the sizes of the
chromosomes seen on pulsed field gel electrophoresis,
suggesting that there are no large gaps in the genome
sequence.
The larger genome size of T. equi as compared to
other piroplasms (Theileria and Babesia) (Table 1) is
also reflected in the number of predicted protein coding
genes (5330), ~ 25% greater than found for T. parva,
T. annulata and B. bovis. While T. equi contains homo-
logs of genes found only in the two Theileria spp. (366),
or B. bovis (137), it has far more unique genes (1985),
which account for the increased size of the genome. The
four species have 2,482 genes in common. T. equi has
two rRNA operons, and 46 tRNA genes.
The apicoplast
The apicoplast is a plastid-like organelle thought to be
derived from a secondary endosymbiotic event with
green algae [20,21]. Like plastids, many of the genes for
metabolic processes in the apicoplast have migrated to
the nuclear genome leaving a remnant genome [22]. In
T. equi, the A+T rich (71%) 47.8 kb apicoplast genome
is larger than those of other piroplasms, due primarily to
Figure 1 Chromosomal map and depiction of synteny between
piroplasms. T. equi (Te), T. annulata (Ta), T. parva (Tp) and B. bovis
(Bb) chromosomes are shown with the T. equi chromosome
represented by the thin black line, and corresponding syntenic
regions from other species’ chromosomes shown as color blocks.
Shades of red represent chromosomes 1, shades of yellow represent
chromosomes 2, shades of green represent chromosomes 3, and
shades of blue represent chromosomes 4. To the left of the Te
chromosome are indicated genes discussed in the manuscript:
purple bars represent locations of ema family members, black bars
represent the location of genes used in phylogenetic analysis and
brown bars represent the two rRNA operons.
Table 1 Genome characteristics of Apicomplexans
Speciesa
Features Pf Tp Ta Bb Te
Size (Mbp) 22.8 8.3 8.35 8.2 11.6
Number of chromosomes 14 4 4 4 4
Total G+C composition (%) 19.4 34.1 32.5 41.8 39.5
Size of apicoplast genome (kbp) 35 39.5 Nre 33 47.8
Size of mitochondrial genome (kbp)b 6 L 6 L 6L 6 L 9 L
# of nuclear protein coding genes 5268 4035 3807 3670 5330
Average CDS length (bp)c 2283 1407 1600 1514 1472
Percent genes with introns 53.9 73.6 70.6 61.5 52.4
Mean length of intergenic region (bp) 1694 405 396 589 550
G+C composition of intergenic region 13.8 26.2 24.1 37 39.3
G+C composition of exons (%) 23.7 37.6 35.7 44 39.8
G+C composition of introns (%) 13.6 25.4 24.4 35.9 37.6
Percent coding 52.6 68.4 72.9 70.2 69.3
Gene densityd 4338 2057 2195 2228 2185
a Pf = P. falciparum, Tp = T. parva, Ta = T. annulata, Bb = B. bovis, Te = T. equi.
b L indicates the presence of a linear genome.
c not including introns.
d genome size/number of protein coding genes.
e not reported.
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(Additional file 1). There are 43 unidirectionally encoded
CDSs in the T. equi molecule, which includes 11 riboso-
mal protein coding sequences. Additionally, each of the
20 tRNA and two rRNA genes are present.
T. equi contains 509 nuclear-encoded proteins poten-
tially targeted to the apicoplast as predicted by Plas-
moAP [23], ApicoAP [24] and/or by homology to genes
for pathways predicted to occur in the apicoplast
(Additional file 2). Similar to other apicomplexans, T. equi
has a complete set of nuclear-encoded enzymes for iso-
prenoid precursor biosynthesis via the methylerythritolphosphate pathway and these activities are predicted to
occur in the apicoplast.
Mitochondrial genome
The mitochondrial (mt) genome is 9001 bp in length,
longer than in other piroplasms and shows evidence of
gene duplication and rearrangement. The T. equi mt se-
quence was recently reported and the authors suggest that
a duplicated CDS (BEWA_044660 and BEWA_044650) is
actually cytochrome c oxidase subunit III (cox3) [25]. Al-
though there is no sequence similarity to known cox3
sequences, T. equi could not conduct respiration without
cox3, and these genes are the only candidate for this func-
tion. Our findings corroborate the linear structure of




The predicted metabolic profile of T. equi is similar to
other piroplasms: most elements of the core pathways
for energy production are present including glycolysis,
pentose phosphate pathway and the tricarboxylic acid
(TCA) cycle. Glycolysis is fully intact with putative
enzymes identified for each stage of the conversion of
sugars to pyruvate for the production of energy, making
carbon the primary energy source. However, since pyru-
vate dehydrogenase (EC 1.2.4.1) is missing from the
T. equi genome (similar to B. bovis and other Theileria
spp.), glycolysis does not seem to be coupled to the TCA
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vate dehydrogenase suggests that the primary function
may be to generate precursors rather than produce
energy. For example, succinyl CoA is a critical biosyn-
thetic precursor for the synthesis of protoheme, used
in cytochromes and many enzymes. Electron transport
pathways in T. equi resemble those reported for P.
falciparum [26]. Lack of the full complement of
NADH dehydrogenase subunits and ATP synthase
peptides makes it questionable as to whether the electron
transport pathway is efficient for the generation of ATP
from the products of glycolysis.
Small molecule synthesis
Metabolic pathway similarities with other sequenced
hemoparasites include the ability to synthesize pyrimi-
dines, limited amino acid biosynthesis, and the lack of a
urea cycle. De novo purine biosynthesis is absent, how-
ever, unlike other piroplasms, hypoxanthine/guanine
phosphoribosyl transferase (BEWA_017710) and adenine
phosphoribosyltransferase (BEWA_017730) are present,
indicating that purine salvage can occur, similar to P.
falciparum. Fatty acid synthesis, heme biosynthesis and
the shikimic acid pathway do not occur in the piroplasms,
although these pathways are present in P. falciparum
[26-29].
T. equi encodes dihydrofolate synthase (EC 6.3.2.17,
BEWA_029790) and a bifunctional dihydrofolate
reductase-thymidylate synthase (EC 1.5.1.3, DHFR-TS,
BEWA_008170) and is predicted to carry out a limited
folate biosynthetic pathway similar to Theileria spp
[27,28]. Notably, a large number of folate-biopterin
transporters were predicted, suggesting that T. equi
imports folate which is then modified into other com-
pounds, chiefly nucleotide precursors. Folate biosyn-
thesis predicts sensitivity to the drug pyrimethamine
cycloguaryl, which has been observed in previous
studies [30], even though T. equi DHFR-TS encodes
the S125F mutation that reportedly confers pyrimeth-
amine resistance in B. bovis and certain Plasmodium sp
DHFR-TS [31].
Phospholipid metabolism
Phospholipid metabolism in apicomplexans is well-
documented, and highlighted by studies in B. bovis
showing a markedly greater phospholipid composition in
infected erythrocytes compared to uninfected erythro-
cytes [32]. T. equi has an increased number of choline/
ethanolamine kinase genes, even relative to B. bovis,
which has a demonstrated increase in phosphatidyl-
choline relative to uninfected bovine erythrocytes [33].
Although only a partial set of enzymes for synthesis of
glycosylphosphatidylinositol (GPI) anchors were detected,
T. equi has been demonstrated to incorporate GPIanchors on membrane proteins [34]. Approximately 2%
of the proteome (132 proteins; Additional file 3) were
predicted to contain both required signatures for GPI
anchors; however, this prediction should be used with
caution as metabolic labeling studies indicate that there
are relatively few GPI anchored protein species within
infected erythrocytes, with members of the EMA family
being the predominantly labeled proteins [34].
Transporter families TransportDB predicts T. equi to
have the most transporters of any hemoparasite gen-
ome sequenced to date [26-29], with 142 in total
(Additional file 4). The most profound increase is
within the ATP-binding cassette (ABC) superfamily of
transporters, with T. equi having 45 members of this
family, compared to just 17 in T. parva, and 9 in B. bovis.
Comparatively, Plasmodium falciparum has 16 members
of the ABC family, most notably ABCB1 (MDR1), a
known mediator of chloroquine and mefloquine resist-
ance [35]. Resistance to chemotherapeutics also occurs in
T. equi, however specific mechanisms of resistance are
unknown. Given the high number of ABC transporter
family members in T. equi, including those of the MDR1
type and orthologues of the other known drug transport
members ABCC1 and ABCG2, it is reasonable to
hypothesize that ABC-mediated transport contributes
to chemotherapeutic resistance in T. equi. Another
expanded family is the Type II general secretory path-
way, which contains 11 transporters, ~three times the
number in the other hemoparasite genomes (Additional
file 4). This pathway moves signal peptide containing
proteins across the cell membrane. The abundance of
signal peptide-containing proteins without predicted
transmembrane domains suggests that T. equi has a
large secretome that utilizes this pathway.
As noted earlier, the folate/biopterin family of trans-
porters is increased (at 5), and thus, T. equi may import
additional folate to contribute to the one carbon pool.
Finally, T. equi has 23 transporter genes in the Major
Facilitator Superfamily (MFS) about twice as many as
other hemoparasites. The MFS transporters include drug
efflux systems, organophosphate:phosphate exchangers
and oligosaccharide:H+ symport permeases and are
single-polypeptide secondary carriers capable only of
transporting small solutes in response to chemiosmotic
ion gradients [36].
Chromosomal synteny
Figure 1 shows blocks of synteny shared between T. equi
and B. bovis, T. parva, or T. annulata. There are rela-
tively few large regions that do not have syntenic
matches in the other piroplasm genomes. Analysis of
chromosome 1 demonstrated that these regions contain
unique proteins (184), without Pfam hits or other
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chromosomes are highly syntenic, and a much more
fragmented pattern of synteny is seen between Theileria
spp. and B. bovis [29,37]. Large regions of synteny are
observed between the Theileria spp. and T. equi, sug-
gesting more recent shared ancestry than for T. equi and
B. bovis, where the blocks of synteny are more fragmen-
ted. T. equi chromosome 1 appears to be evolutionarily
related to Thelieria spp. chromosomes 1 and 2. The an-
cestral Theileria chromosome 2 has split to provide ele-
ments of T. equi chromosomes 1 and 2. Approximately
2/3 of each of T. equi chromosomes 2 and 3 share syn-
teny with Theileria spp. chromosomes 1 and 4, respect-
ively. The remaining 1/3 of each of these chromosomes
contains more of the B. bovis specific lineage sequences
or unique sequences. With a few exceptions, T. equi
chromosome 4 and is syntenic to both T. parva and
T. annulata chromosome 3. Notably, the orthologous
gene matches extend to the ends of each of the T. equi
chromosomes demonstrating the lack of telomerically
located species-specific gene families and repeats seen in
other hemoparasites [26,28].
Paralogous families
TribeMCL placed 2614 proteins in 334 families ranging
in size from 2 to 356 members (Additional file 5). Many
of the families, including the two largest, have little
significant sequence identity, for any two proteins, in
pairwise comparisons; however, this result did not
change when we used more stringent parameters for
clustering. Therefore, we analyzed the families for
common functional annotation and show that most
members of a given family share a common functional
domain or feature (Additional file 5). Exceptions are
family 1 and family 17. A few families have high levels
of sequence conservation and readily identifiable func-
tional attributes found through Pfam hits. For example,
family 11 contains 42 members with hits to Pfam
PF00005, a family of ABC transporters. A survey of
T. equi protein families that have at least 20 members
revealed that most of these families are comprised of
functional attributes similar to those represented in
similar scans of B. bovis and Theileria spp. None of
the T. equi families appear to contain a family of known
immunodominant antigenically variable genes, nor are
any of the families telomerically associated. Notable
families are presented below.
Family 3
Containing 109 members, this family has ~30% sequence
conservation with a repeat gene family in T. annulata
(Tar). The Tar genes were reported to be analogous to
the Tpr genes of T. parva, however Family 3 does not
share significant sequence identity with Tpr [27]. Mostmembers of Family 3 encode a protein of ~50 KDa, with
no signal peptide. Although the function of these pro-
teins in Theileria is unknown, it is thought that these
genes in T. parva are involved in the generation of
diversity [28], with the Tpr repertoires appearing to be
isolate specific [38]. Like T. annulata, the T. equi Family
3 genes are distributed throughout all four chromo-
somes. Expressed Sequence Tags (ESTs) were found
for only seven of the Family 3 genes suggesting that
only a small number of these genes are expressed at
a given time.
Equi merozoite antigen (EMA) family
Family 29 contains 10 members related to the best char-
acterized protein in T. equi, Equi Merozoite Antigen 1
(EMA1). EMA1, a 34 kDa immunodominant protein, is
used as the basis of a cELISA diagnostic test for T. equi,
as this highly conserved antigen is recognized by sera
from infected animals worldwide [39]. EMA1 has a GPI
anchor, a putative erythrocyte-binding domain shared
with certain hemotoxins, and surface-exposed epitopes
[34]. Immunoprecipitation of T. equi proteins by serum
from a horse challenged twice at a 2-month interval with
T. equi revealed that in addition to EMA1, EMA2 has a
GPI anchor and detectable antibody responses were lim-
ited to EMA1-3 proteins [34,40]. Although ema1 was
originally described as a single copy gene, genomic ana-
lysis has revealed a total of 10 genes in this family. The
amino acid identity ranged from 17 to 55% in pairwise
comparisons of family members. EMA2 was previously
characterized as 50% identical to EMA1, and is also an
immunodominant GPI-anchored protein. EMA1 is more
highly expressed in blood stages of the parasite relative
to EMA2 while EMA2 is more highly expressed in the
tick salivary gland during transmission feeding than
EMA1 [2]. These two proteins, along with a third mem-
ber of this family (EMA3) have been shown to interact
with the erythrocyte cytoskeleton [40,41]. A single
ortholog of these proteins have been identified in T.
annulata (TAMS1) and T. parva (mMPSA) but not in
other Apicomplexa [42,43]. At least one EST was found
for each ema family member, with the exception of
BEWA_028210 and BEWA_047350, demonstrating that
transcription in blood stage parasites takes place for
most family members.
A core set of 8 ema genes are predicted to encode pro-
teins of ~30 kDa, with the remaining two encoding
markedly differently sized proteins, one being truncated
(BEWA_034050) and the other (BEWA_047350) being
much longer and only having similarity in the C-
terminal domain (Additional file 6). Interestingly, the
truncated gene produces a transcript, based on EST ana-
lysis, as long as the other family members, but which
encodes multiple stops in the 5’ region preventing
BA
DC
Figure 2 Analysis of schizont-infected PBMC in vitro. The
capacity of T. equi (Florida) to infect PBMC in vitro was assessed by
light microscopy (A, B) and IFA (C, D). Fresh PBMC from adult
Arabian horses were cocultured with tick salivary gland
homogenates containing T. equi sporozoites. Infected and
uninfected control PBMC were sampled daily for cytospin
preparation and Diff-Quick staining [representative
photomicrographs of uninfected control cultures (A) and T. equi
infected cultures (B) on day 9]. Panel B includes three schizont-
infected leukocytes, with multiple, oval to round, 1–2 μm diameter,
purple nuclei (developing merozoites). To confirm the
intracytoplasmic organisms were T. equi, uninfected control and
infected cultures were labeled with antibody specific for equine
merozoite antigens 1 and 2 [mAb 36/133.97 (anti-EMA 1/2)]. In the
infected culture wells (D), intracytoplasmic schizonts and developing
merozoites were specifically labeled with anti-EMA 1/2 (secondary
goat anti-mouse IgG1 conjugated with FITC-green; Nuclear
stain = DAPI). Cells from the uninfected control cultures were not
labeled with anti-EMA 1/2 (representative data in panel C).
Scale bar = 10 μm.
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member is in the process of becoming a pseudogene by
disruption of the full reading frame, and an indication
that the family may be reduced in size over time.
The ema genes are distributed across the genome, with
no evidence of clustering or telomeric association. There
is no evidence that the ema genes undergo recombin-
ation or dynamic sequence variation, as might be
expected if these genes are involved in immune evasion
[16,44]. Therefore, despite their immunodominance,
their limited number and lack of a structural basis for
variation do not fit with the paradigms seen for P.
falciparum var genes (encoding PfEMP1) or B. bovis
ves1 genes (encoding VESA1) where evasion of the im-
mune response through emergence of variable surface
antigens is a well characterized mechanism of parasite
persistence [18,45].
FAINT domains
While not a protein family per se, the FAINT domain was
originally detected in T. annulata and T. parva as a
stretch of 70 amino acids and was named “Frequently
Associated IN Theileria”; subsequently, Pfam04385, the
FAINT domain – a domain of unknown function
(DUF529) was established and was found to be over repre-
sented in proteins predicted to be secreted [27,28]. T. equi
proteins may have multiple FAINT domains and are typic-
ally classified into several protein families. T. equi contains
271 proteins with 560 hits to Pfam04385. FAINT domains
are not reported for B. bovis or P. falciparum. The FAINT
domain containing genes are distributed throughout the
T. equi genome.
T. equi does not contain homologs of putative Theileria
host cell transforming genes
Although host cell transformation has not been reported
for T. equi, it has been reported to invade the lympho-
cyte and develop to a macroshizont stage [13]. In T. parva
and T. annulata, the macroschizont life cycle can induce
transformation of the infected cell [46]. To assure that
the T. equi isolate used in this study infected equine
lymphocytes/PBMCs, equine PBMCs were infected with
sporozoites obtained from infected adult male Rhipice-
phalus microplus ticks. To verify infection of equine
PBMC cultures, EMA-1 and EMA-2 monoclonal anti-
bodies were tested by immunofluorescence and bound
corresponding T. equi antigens within equine PBMCs
(Figure 2). The lack of observed transformation in this
close relative of pathogens (T. parva and T. annulata)
that do transform their host led us to search the T. equi
genome for putative host cell transformation genes to
see if these genes were retained in the genome. A set of
genes [46] identified as potential manipulators of host
cell phenotype in T. annulata and T. parva was used toexplore the T. equi genome for orthologous genes, along
with the EST expression data. T. parva and T. annulata
express prohibitin in macro- and microschizonts, while
T. equi expresses the ortholog (BEWA_014000) in
erythrocyte-stage parasite ESTs. Prohibitin is reported to
be a tumor suppressor that is involved in pathways that
lead to immortalization, however, this gene was also
identified in B. bovis, which does not undergo trans-
formation [46]. Similarly, T. equi has several homologs
of cyclophilins, which have been linked to transformation.
This gene is found in B. bovis, T. parva and T. annulata,
again, limiting the implication of this gene product as a
host cell transforming factor. T. equi does not have a
homolog of the Theileria schizont AT hook (TashAT)
family of proteins. The AT hooks function as nuclear
localization signals and DNA binding domains, and may
function in cell transformation. Likewise, TashHN (host
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TashHN is expressed by Theileria macroschizonts that
have lost the ability to form merozoites, while SuAT1 is a
schizont protein with characteristics of the TashAT family,
that can modulate the phenotype of cultured bovine
macrophages by altering the expression profile of cyto-
skeletal proteins in a manner similar to that seen during
infection.Vaccine candidates
The RAP-1 Family
Members of the rhoptry associated protein-1 (rap-1)
gene family are candidates for vaccine development in
Babesia spp. Immunization of cattle with purified native
RAP-1 of B. bigemina resulted in partially protective
responses, and is one of three antigens in a recombinant
vaccine developed in Australia [47]. However, recombin-
ant B. bovis RAP-1 failed to elicit protective immune
responses in vaccine trials. The RAP-1 proteins of Babe-
sia spp. are characterized by a signal peptide followed by
a cysteine-rich region and several short conserved se-
quence motifs within the first 300 amino acids. Thus,
the N-terminal region of all known Babesia RAP-1 pro-
teins contains the “rap-1 domain”. The C-terminal
regions are less conserved among Babesia species. B.
bovis contains two identical rap-1 genes in tandem and
a shorter rap-1 related protein gene (RRP) located ~30
kbp from the rap-1 locus. Three rap-1 genes were iden-
tified in T. parva and four in T. annulata. The general
structure of rap-1 in Theileria spp. is different from that
in B. bovis, with the Theileria proteins containing
more than one rap-1 domain. The T. equi rap-1 locus
contains two tandemly arranged genes: BEWA_037610
contains two rap-1 domains, and BEWA_037600 con-
tains three rap-1 domains. Thus, the arrangement of
rap-1 domains in T. equi resembles that found in
other Theileria spp.Apical Membrane Antigen 1
T. equi Apical Membrane Antigen-1 (AMA-1; BEWA_
036830) is a microneme protein with surface exposed
epitopes that has orthologs in hemoprotozoan Apicom-
plexa, as well as Toxoplasma gondii [48]. AMA-1 anti-
body has inhibitory effects on parasite replication
in vitro, and has been protective in animal models
[49-51]. T. equi and B. bovis AMA-1 lacks the N-terminal
extension found in other Theileria spp. AMA-1 has a
set of conserved cysteine residues which may contribute
to a conserved architecture through disulfide bonds.
Plasmodium AMA-1 is polymorphic [52], and the degree
of polymorphism must be assessed in T. equi before
AMA-1 can be considered as a vaccine candidate for
this species.Thrombospondin-related anonymous protein (TRAP)
Conserved hypothetical proteins BEWA_005690 and
BEWA_005710 fall into a Cluster of Orthologous
Groups (COG) with apicomplexan genes annotated as
TRAP, sporozoite surface protein or microneme protein
2 [53]. Although these molecules have been effective
immunogens in Plasmodium [54], the T. equi proteins
have low sequence similarity and it is unclear whether
these would be effective vaccine candidates.
Other prophylaxis opportunities suggested by comparative
genomics
HAP2 is a protein essential for membrane fusion during
zygote formation in Plasmodium that has a homolog in
numerous species, including Leishmania and T. parva
[55]. A positional homolog i.e., a gene with very low se-
quence identity couched within a highly conserved
locus, exists in B. bovis (BBOV_III006770) and T. equi
(BEWA_7380). This target could provide a novel method
of transmission blocking through gene knock out, thus
preventing gamete fusion and tick transmission of a
modified live vaccine. Membrane Occupation and Rec-
ognition Nexus protein (MORN1) seems to be related
to cell division in all Apicomplexa studied, and func-
tions in both asexual and sexual reproduction [56]. A
common and effective prophylaxis for members of the
phylum could come from targeting this molecule.
BEWA_033160 is annotated as a MORN repeat
domain-containing protein, and falls in to a COG with
proteins from Plasmodium, Theileria, and B. bovis, as
well as Toxoplasma gondii and Cryptosporidium parvum.
Heme Detoxification Protein (HDP) has a role in detoxi-
fying heme that results from parasite metabolism of
hemoglobin by polymerizing the heme into hemozoin
[57]. BEWA_011450, a putative HDP, is in a COG con-
served across apicomplexan organisms. This hypothetical
target for prophylaxis would allow toxic levels of heme to
accumulate through inactivation of HDP.
p67 locus synteny T. parva p67 is an abundant sporo-
zoite surface antigen, and along with its homolog from
T. annulata (SPAG-1) has been shown to induce neu-
tralizing antibody, and immunity to theileriosis and has
been a target of vaccine development [58]. A positional
homolog was identified in B. bovis (BBOV_IV007750)
[29,59] and T. equi contains a gene at the same location
(BEWA_015160). EST data show that BEWA_015160 is
transcribed. The prospect that the genes occupying this
position in syntenic loci have similar functions during
parasite infection but tailored to different hosts makes
them interesting candidates for vaccine studies.
The T. parva six A set of six T. parva antigens that are
the targets of CD8+ T lymphocyte responses in immune
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Tp8 [60]. Tp2 is a surface protein whose homolog is also
expressed in T. annulata. All of these vaccine candidates
except hypothetical protein Tp1 have orthologs in T.
equi and have been demonstrated to be transcribed in
erythrocyte stages via EST analyses. While the signifi-
cance of piroplasm stage expression is unclear, these T.
equi proteins may have utility as vaccine components
based on observations in T. parva.
Phylogenetic analysis of piroplasms
Mehlhorn and Schein renamed Babesia equi as T. equi
in 1998 due to the description of a lymphocytic stage for
this parasite [8]; however, while this classification has
been well adopted, it is not borne out by phylogenetic
studies. The phylogenetic position of T. equi was
explored using 150 deduced amino acid sequences
(Additional file 7) from eight fully sequenced apicom-
plexan genomes. Results of the Bayesian analysis (Figure 3)
support two possible scenarios: the four piroplasm species,
T. parva, T. annulata, B. bovis and T. equi, represent a
single genus or alternatively, these species represent three
separate genera. Maximum Parsimony (MP) analyses of
individual sequences resulted in many different treeFigure 3 Phylogenetic tree of sequenced apicomplexans.
Posterior probability distribution tree representing best likelihood
score (probability of 1.0) following Bayesian analysis of 150
concatenated polypeptides across eight taxa. Taxa codes are Pf
(Plasmodium falciparum), Pv (Plasmodium vivax), Tg (Toxoplasma
gondii), Cp (Cryptosporidium parvum), Bb (Babesia bovis),
Te (Theileria equi), Tp (Theileria parva), Ta (Theileria annulata).topologies; however, the four most commonly recovered
topologies (Additional file 8) represent 78% of all trees.
Consistent with Bayesian inference, the three most com-
mon topologies (Additional file 8, topologies a-c) suggest
that T. equi shares a more recent common ancestor with
the two Theileria species than with B. bovis. MP analysis
of the concatenated datasets unambiguously recovered
this same relationship of the four piroplasm species, and
completely corroborated the tree estimated using Bayesian
inference. Finally, maximum likelihood analyses of the
concatenated datasets using a variety of substitution mod-
els (JTT, MTREV, WAG, RTREV, CPREV, VT) consist-
ently yielded the same estimates, which completely
corroborate the trees generated by Bayesian inference and
MP analyses of the concatenated datasets (Additional file
8). Collectively, robust phylogeny estimation, which uti-
lized three separate optimality criteria and various models
of protein evolution, consistently placed T. equi as a sister
taxon to the Theileria clade, with all three of these piro-
plasm species subtended by B. bovis.
Previous studies employing 18S rRNA sequences
across many piroplasmid taxa also revealed uncertainty
in the phylogenetic position of T. equi and several other
piroplasms [61,62]. Our robust phylogenetic analyses,
which strongly imply the placement of T. equi as sister
to the Theileria clade provide stability to piroplasm sys-
tematics. Our goal was to determine if a selection of
orthologous polypeptides from completed Babesia and
Theileria genomes could be used to discriminate the
appropriate phylogenetic position of T. equi. However,
species sampling was restricted by available complete
genome sequences and is too limited to completely re-
solve this issue. A more appropriate solution may be
to place T. equi in a genus distinct from both Theileria
and Babesia, as has been previously suggested [9]. This
option would likely result in the renaming of some
related taxa including Cytauxzoon felis, which groups
as the closest relative of T. equi in the 18S rRNA
study [61]. Importantly, our analysis revealed a set of 50
informative genes that could be analyzed in a broader
sampling of Piroplasmida taxa to gain a greater under-
standing of the evolutionary relationships of the piro-
plasms (Boxed sequences in Additional file 7).
Conclusions
Characteristics of genes involved in immune evasion
leading to persistence include immunodominance, highly
variable domains, and membership in a multigene family.
Within the phylum Apicomplexa, B. bovis contains the
119 member ves1 gene family which encodes the VESA1,
known to vary by gene conversion and participate in im-
mune evasion; and P. falciparum contains the 59 mem-
ber var gene family encoding PfEMP1, which utilizes
several mechanisms to generate antigenic variation
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family wasn’t detected in T. equi, instead, it contains a
small family of immunodominant proteins including
EMA1, EMA2, EMA3 and seven additional members
which have marked variation throughout each gene.
While the precise mechanism(s) of antigenic variation
provided by the ema family isn’t yet known, we
hypothesize that EMA family members provide antigenic
variation and immune escape through a protein reassort-
ment strategy that generates immune escape variants by
creating novel heteromers of EMA on the cell surface.
The genome sequence also revealed a 109 member gene
family (Family 3); however these proteins have never
been detected by immune serum, suggesting that they
are not contributing to immune evasion. Genome se-
quencing allowed an exploration of the phylogenetic pos-
ition of T. equi at a depth not previously feasible;
demonstrating that this species clusters consistently with,
and as a sister lineage to other Theileria spp. Genome
sequences for closely related piroplasms may allow “fine
tuning” of the T. equi phylogenetic position and appro-
priate naming of the lineage to which this species
belongs. Finally, the genome sequence will provide an in-




Animal experiments were approved by the Institutional
Animal Care and Use Committee at University of Idaho,
USA, in accordance with institutional guidelines based
on the U.S. National Institutes of Health (NIH) Guide
for the Care and Use of Laboratory Animals.
Parasite culture
For sequencing
Theileria equi USDA (Florida) stabilate (PPE: 0.64%) gen-
erated from infection of a spleen intact horse (H2) was
inoculated intravenously into a splenectomized horse
(H047). When the parasitemia reached 16% as determined
by Giemsa stained blood smear examination, blood was
collected into a flask containing glass beads for defibrina-
tion. The blood was washed three times with HBSS/
10mM EDTA to remove the white blood cells (WBC).
Erythrocytes were purified using histopaque 1077 follow-
ing the manufacturer’s protocol. Microscopic examination
determined WBC contamination to be <5 WBC per 1 ul
of blood. T. equi genomic DNA was extracted from the
purified erythrocytes using components of the Gentra
Puregene DNA Purification System (Kit D-5000).
T. equi sporozoite infection of PBMC in vitro:
To obtain the sporozoites need for in vitro PBMC infec-
tion, one thousand adult male Rhipicephalus microplusticks were acquisition fed on a T. equi (Florida strain)
merozoite stabilate-infected adult horse during ascend-
ing parasitemia for eight days (acquisition feeding). Fol-
lowing acquisition feeding, fed ticks were incubated for
two days at 15°C with 94% relative humidity and a 12 hr
photo period, and subsequently transmission fed on a
naïve horse to induce final maturation of sporozoites
into their infectious stage. On day seven of the transmis-
sion feeding, 240 live adult males were recovered and
salivary gland pairs were dissected aseptically, and
sporozoite extracts prepared using established methods.
Briefly, collected salivary glands were washed in 0.5 ml
of complete media (RPMI 1640 supplemented with 10%
heat inactivated fetal bovine serum, 200 IU/ml benzyl
penicillin, 200 ug/ml streptomycin sulphate, 50 μg/ml
gentamycin and 5 × 10-5 M 2-mercaptoethanol) and
crushed in a glass homogenizer to release sporozoites.
The homogenate was then centrifuged at 300 g for 5
min and the supernatant containing sporozoites was col-
lected and adjusted to 10 tick equivalents/ml. One ml of
the sporozoite extract was inoculated into each of ten
wells of a 24-well plate containing 2 × 106 PBMC from
an uninfected horse. Starting on day nine post-inoculation,
cell culture aliquots were cytospun and examined micro-
scopically for infection following Diff-Quick staining.
Sequencing
DNA from T. equi USDA (Florida) strain was used to
construct a small and large insert plasmid library as well
as a bacterial artificial chromosome library. A total of
100,835 high quality sequence reads (822 bp average
read length) were generated and assembled using the
Celera Assembler (http://sourceforge.net/projects/wgs-
assembler/), resulting in 119 scaffolds consisting of 495
contigs. A BAC library was end sequenced to generate
an additional 3023 reads which were used to confirm the
assembly and for targeted sequencing in the closure
phase. Gaps were closed by a combination of primer
walking and transposon based or shotgun sequencing of
medium insert clones, BAC clones or PCR products.
The genome sequence has been deposited in GenBank
under accession number ACOU00000000. A cDNA li-
brary was constructed using cultured infected erythro-
cytes (Florida strain) using the Creator SMART cDNA
library construction kit (Clontech). cDNA in the size
range of 0.3 -2kb was normalized using the Trimmer
normalization kit (Evrogen). 7629 sequences (GenBank
Accession #s HS032712 - HS040340) were generated
and assembled into 2355 contigs using PASA [63].
Genome annotation
Genes encoding tRNA’s were identified using tRNA
scan-SE [64]. Gene models were predicted using the ab
initio gene finding programs GeneZilla, GlimmerHMM
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full length high confidence genes in the training set. The
training data was manually constructed and inspected
for its alignment against highly conserved protein
sequences using the AAT package [68] and PASA [63]
to align the ESTs to the genomic sequence with a strin-
gent criteria of 95% identity over 90% length using gmap
[69]. Data were combined and consensus gene models
were derived using Evidence Modeler EVM [70]. The
consensus gene models were manually checked for obvi-
ous errors. Such models were corrected using a Java
based tool called Neomorphic Annotation Station [71].
Functional annotation was as for B. bovis [29]. In
addition, EC numbers were assigned in an automated
fashion using PRIAM [72] and metabolic pathways con-
structed using SRI’s pathway tools [73]. TransportDB is
a relational database that was used to determine trans-
porter complement [74]. TribeMCL [75] was used with
default parameters to construct a database of genes that
are part of paralogous families of proteins represented in
the genome. The method is a sequence similarity
matrix-based Markov clustering method.
Comparative genome analysis
Sybil (http://sybil.sourceforge.net) was used to create an
all-versus-all BLASTP search using the proteomes of T.
equi, B. bovis, T. parva,T.annulata, P. falciparum, P. vivax,
C. parvum and T. gondii. These outputs were subjected to
Jaccard clustering, placing proteins into distinct clusters
for each proteome. Clusters from different proteomes were
linked based on best bidirectional BLASTP hits between
them to provide Jf-COGs. A minimum block size of five
with one gap was allowed in the analyses.
Immunofluorescence assay
To verify PBMC cultures were infected with T. equi,
cytospin preparations were made for immunofluores-
cence antibody microscopy on day nine after cell culture
inoculation. After drying, cytospin preparations were
fixed in 1% formalin for 2 min and primarily labeled
with T. equi EMA-1 and EMA-2-specific monoclonal
antibody 36/133.97. Bound antibody was detected using
fluorescein-conjugated goat anti-mouse IgG1 and subse-
quently visualized by fluorescence microscopy.
Phylogenetic analysis
The phylogenetic position of T. equi relative to other piro-
plasm species with published genomes, namely T. parva,
T. annulata, and B. bovis was determined based on 150
polypeptide sequences, and rooted with four other api-
complexan taxa: P. vivax, P. falciparum, T. gondii, and C.
parvum. Polypeptides were selected from single copy
genes identified in all eight species. COGs (clusters of
orthologous genes) were defined using an in-housecomparative pipeline, which starts with BLASTP among
protein sequences within and across species. We used the
BLOSUM62 matrix with expected value 10-5. Jaccard clus-
tering was then performed twice, once to form within-
species clusters of paralogous genes and a second time to
derive a set of multi-species COGs. In the first case, we
used an 80% identity cutoff over a minimum of 70% of the
length of the smallest protein and a link score of 0.6. In
the second, we set the identity cutoff at 50% over >70%
length, and Jaccard coefficient cutoff of 0 for edge pruning.
In order to minimize ambiguous amino acid homology
assignments that can occur when indels are present,
peptides were chosen that have the smallest protein
size variation across all species (Additional file 7 for
list). Protein sequences within a COG were aligned
with ClustalW using default parameters [76].
Three methods were used to reconstruct the phylogen-
etic relationships among the sequences: i) maximum
parsimony (MP) with exhaustive tree search, and other-
wise default parameters as implemented in PAUP
v4.0b10 [77], ii) Bayesian inference (BI) implemented in
MrBayes v3.1.2 [78], and iii). maximum likelihood (ML)
estimation as implemented in RAxML v.7.2.8 [79]. Ini-
tially, the individual protein datasets were analyzed with
maximum parsimony, with branch support assessed with
1000 bootstrap replicates. The 150 datasets were subse-
quently concatenated and again analyzed using MP with
exhaustive tree search and similar bootstrapping proced-
ure. For BI of the concatenated datasets, the amino acid
transition matrix was set to a mixture of models with
fixed rate matrices (Poisson, Jones, Dayhoff, Mtrev,
Mtmam, Wag, Rtrev, Cprev, Vt and Blosum) of equal
prior probabilities, and otherwise default parameters.
Four runs of MrBayes were conducted, each with 4
chains. Two of those runs ran for 567,000 generations
and the other two ran for 2,365,000 generations. Conver-
gence was achieved (Potential Scale Reduction Factor,
PSRF=1.00) for all model parameters estimated, includ-
ing tree length (mean-1.79), the amino acid model
(Wag, with posterior probability=1.00), and the tree top-
ology. ML analyses of the concatenated datasets all
implemented a gamma model of rate heterogeneity with
estimation of the proportion of invariable sites. Six separ-
ate amino acid substitution models (JTT, MTREV, WAG,
RTREV, CPREV, VT) were utilized. Branch support was
assessed with 1000 bootstrap pseudoreplications.
Note: Two additional genome sequences of interest
were published while this article was in review. T. orien-
talis does not transform it’s host cell and has been com-
pared to T. parva and T. annulata to identify putative
mediators of leukocyte transformation [80]. B. microti
phylogeny was analyzed using 316 single copy genes and
found to clade separately to T. parva, T. annulata and
B. bovis [81].
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Additional file 1: Figure. Depiction of the T. equi apicoplast genome
gene arrangement, showing unidirectional coding of genes. Known
enzymes shown in red, ribosomal proteins in green, rRNA sequences in
yellow, and groupings of tRNA molecules in blue. Location of conserved
hypothetical (gray), and hypothetical (black) protein-encoding genes are
shown by arrows or bars. Members of the three expanded gene families
are marked with either “*”, “¡” or “^” to indicate similar genes. The
molecule is depicted as linear, though not experimentally demonstrated
to be either circular or linear.
Additional file 2: Table. Nuclear encoded genes potentially targeted to
the apicoplast.
Additional file 3: Table. GPI anchored proteins predicted by
GPI-SOM.
Additional file 4: Table. Transporter comparison B. bovis, T. equi, and T.
parva.
Additional file 5: Table. 30 largest protein families.
Additional file 6: Figure. Alignment of EMA family sequences. Residues
highlighted in yellow are conserved among all family members, and
those in blue conserved among the majority of family members. Dashes
represent gaps introduced to accommodate non-conserved stretches of
sequence.
Additional file 7: Table. Proteins used in phylogenetic analysis.
Additional file 8: Figure. Phylogenetic trees. A: Most frequently
recovered trees from maximum parsimony analysis of 150 polypeptides
conserved among eight taxa, showing the number of times tree
recovered out of 210 total topologies. Value above the line represents
the number times that branch was recovered out of total times whole
topology was recovered , and value below the line is percentage
bootstrap support for that branch out of 1000 replicates. The bootstrap
support for the individual MP trees was calculated for each individual
dataset, and averages across all of the individual trees are presented. B:
Single most parsimonious tree estimated from the concatenated dataset
of the 150 polypeptides. Taxon codes are Cp: Cryptosporidium parvum,
Tg: Toxoplasma gondii, Pf: Plasmodium falciparum, Pv: Plasmodium vivax,
Bb: Babesia bovis, Te: Thieleria equi, Ta: Theileria annulata, Tp: Theileria
parva. C: Trees estimated with maximum likelihood using six different
models of amino acid substitution. Branch support was assessed with
1000 bootstrap pseudoreplications.
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